Hey J A, Gherezghiher T, Koss M C
Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):258-63. doi: 10.1007/BF00515551.
Intravenous administration of clonidine hydrochloride (3-100 micrograms/kg) produced a dose-dependent pupillary dilation in anaesthetized rats. All experiments were carried out in rats in which vagosympathetic nerve trunks were sectioned bilaterally at the cervical level. Clonidine-induced mydriasis was present only in those preparations having intact parasympathetic neural tone to the iris. Depletion of CNS monoamines by more than 95% with reserpine (5 mg/kg) and alpha-methyl-para-tyrosine (2 X 300 mg/kg) failed to alter the dose-response relation to clonidine. Pretreatment with the alpha-2-adrenoceptor antagonist, yohimbine hydrochloride (1.5 mg/kg), produced about a 10-fold shift to the right in the pupillary dose-response curve to clonidine. Yohimbine administered after the highest dose of clonidine also antagonized the mydriatic response. The above results suggest that clonidine acts on CNS post-synaptic alpha-2-adrenoceptors to produce mydriasis by withdrawal of parasympathetic neural tone to the iris. In an attempt to assess the physiological substrate(s) involved, mydriatic responses, due to parasympatho-inhibition, were evoked by electrical stimulation of ascending (sciatic nerve and medullary) and descending (hypothalamic) pathways. Yohimbine (0.3 and 1.0 mg/kg) produced a dose-dependent inhibition of the pupillary dilation evoked by stimulation of the sciatic nerve and medullary loci, whereas these doses of yohimbine failed to alter the dilation in response to hypothalamic stimulation. Similarly, monoamine depletion greatly antagonized the pupillary dilation elicited by sciatic nerve and medullary stimulation without significantly affecting mydriasis due to hypothalamic stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)
静脉注射盐酸可乐定(3 - 100微克/千克)可使麻醉大鼠的瞳孔出现剂量依赖性扩张。所有实验均在双侧颈段切断迷走交感神经干的大鼠身上进行。可乐定诱导的瞳孔散大仅出现在那些对虹膜具有完整副交感神经张力的制剂中。用利血平(5毫克/千克)和α-甲基对酪氨酸(2×300毫克/千克)使中枢神经系统单胺耗竭超过95%,未能改变对可乐定的剂量反应关系。用α-2肾上腺素能受体拮抗剂盐酸育亨宾(1.5毫克/千克)预处理,使可乐定的瞳孔剂量反应曲线向右移动约10倍。在给予最高剂量可乐定后再给予育亨宾也能拮抗瞳孔散大反应。上述结果表明,可乐定作用于中枢神经系统突触后α-2肾上腺素能受体,通过撤回对虹膜的副交感神经张力来产生瞳孔散大。为了评估所涉及的生理底物,通过电刺激上行(坐骨神经和延髓)和下行(下丘脑)通路诱发因副交感神经抑制引起的瞳孔散大反应。育亨宾(0.3和1.0毫克/千克)对刺激坐骨神经和延髓部位诱发的瞳孔扩张产生剂量依赖性抑制,而这些剂量的育亨宾未能改变对下丘脑刺激的扩张反应。同样,单胺耗竭极大地拮抗了坐骨神经和延髓刺激引起的瞳孔扩张,而对下丘脑刺激引起的瞳孔散大没有显著影响。(摘要截断于250字)